Detalhe da pesquisa
1.
Differences in presentation and survival of Asians compared to Caucasians with ovarian cancer: An NRG Oncology/GOG Ancillary study of 7914 patients.
Gynecol Oncol
; 154(2): 420-425, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31229298
2.
Counterpoint: Is There Still a Role for Intraperitoneal Platinum Therapy in Ovarian Cancer? There Is No Role for IP Chemotherapy in Ovarian Cancer.
Oncology (Williston Park)
; 32(2): 75, 77-9, 2018 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29492948
3.
Phase III Trial of Carboplatin and Paclitaxel Compared With Cisplatin and Paclitaxel in Patients With Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncology Group Study.
J Clin Oncol
; 41(25): 4077-4083, 2023 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37643542
4.
Reclassification of serous ovarian carcinoma by a 2-tier system: a Gynecologic Oncology Group Study.
Cancer
; 118(12): 3087-94, 2012 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22072418
5.
The search for predictive patterns in ovarian cancer: proteomics meets bioinformatics.
Cancer Cell
; 1(2): 111-2, 2002 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-12086867
6.
The impact of disease distribution on survival in patients with stage III epithelial ovarian cancer cytoreduced to microscopic residual: a Gynecologic Oncology Group study.
Gynecol Oncol
; 122(3): 521-6, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21683993
7.
RAD001 inhibits human ovarian cancer cell proliferation, enhances cisplatin-induced apoptosis, and prolongs survival in an ovarian cancer model.
Clin Cancer Res
; 13(14): 4261-70, 2007 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17634556
8.
Clinical trial endpoints in ovarian cancer: report of an FDA/ASCO/AACR Public Workshop.
Gynecol Oncol
; 107(2): 173-6, 2007 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-17950384
9.
Prevention and early detection of ovarian cancer: mission impossible?
Recent Results Cancer Res
; 174: 91-100, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-17302189
10.
Focus on epithelial ovarian cancer.
Cancer Cell
; 5(1): 19-24, 2004 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-14749123
11.
Systemic therapy for ovarian cancer: current status and new treatments.
Semin Oncol
; 33(2 Suppl 6): S3-11, 2006 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-16716797
12.
Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study.
J Clin Oncol
; 21(17): 3194-200, 2003 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-12860964
13.
Gemcitabine and carboplatin in second-line ovarian cancer.
Semin Oncol
; 32(4 Suppl 6): S4-8, 2005 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-16143161
14.
Intraperitoneal chemotherapy for ovarian cancer.
N Engl J Med
; 354(15): 1641-3; author reply 1641-3, 2006 Apr 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-16611959
15.
Future directions in the treatment of ovarian cancer.
Semin Oncol
; 29(1 Suppl 1): 32-42, 2002 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-11840418
16.
Gynecologic Oncology Group (GOG-USA) trials in ovarian cancer.
Adv Exp Med Biol
; 622: 131-43, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-18546624
17.
The management of recurrent ovarian cancer.
Semin Oncol
; 34(2 Suppl 2): S1-15, 2007 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-17512352
18.
Maintenance therapy in advanced ovarian cancer: progression-free survival and clinical benefit.
J Clin Oncol
; 21(13): 2451-3, 2003 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-12829660
19.
Recurrent ovarian cancer: evidence-based treatment.
J Clin Oncol
; 20(5): 1161-3, 2002 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-11870155
20.
Symptoms of ovarian cancer--where to set the bar?
JAMA
; 291(22): 2755-6, 2004 Jun 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-15187058